Home » »

Elie Besserer-Offroy, Ph.D.

Principal Investigator | Assistant Professor (Research)
THERNOVCA Excellence Research Chair 
U1086-INSERM, Baclesse Comprehensive Cancer Center (France)


Dr. Besserer-Offroy is an Assistant Professor (Research) of Nuclear Medicine and Pharmacology at the Inserm Research Unit 1086 – Anticipe (France). Dr. Besserer-Offroy received his ASc in Biological Sciences in 2009 from the Université de Franche-Comté (France), which he followed with a BMSc in Medical Biochemistry from the Université Claude-Bernard – Lyon I (France) in 2010. Then, he crossed the Atlantic Ocean and completed his PhD in Pharmacology at the Université de Sherbrooke under the supervision of Prof. Sarret in 2017. During his graduate studies, Dr. Besserer-Offroy was interested in  characterizing novel G protein-coupled receptors (GPCRs) ligands for the treatment of chronic pain but also in deciphering cellular signaling pathways associated with the physiological effects observed in vivo of such GPCRs. In 2017, Élie was an Assistant Research Scientist for an academic consortium partnering with a biotech company. During this time, he worked on on the development of a new generation of ion channel biosensors with preclinical applications in target validation and drug discovery. From 2018 to 2021, Élie was a Post-Doctoral Fellow in the Department of Pharmacology and Therapeutics at McGill University under the mentorship of Dr. Terry Hébert where he studied the functional role of GPCR heterodimerization in the signaling processes in vitro and in vivo. From 2019 to 2021, he has been a Faculty Lecturer in the School of Pharmacy at Université de Montréal, responsible of a Physiology class for PharmD students.

Before joining Inserm Research Unit 1086 – Anticipe, Dr. Besserer-Offroy was Professor of Pharmacology and Nuclear Medicine at the David Geffen School of Medicine, University of California, Los Angeles.

  • Diplomas

Ph.D. in Pharmacology
Université de Sherbrooke, Québec, Canada

Certificate in Project Management
École Centrale de Lille, France

M.S. in Pharmacology
Université de Sherbrooke, Québec, Canada

B.S. in Medical Biochemistry
Université Claude-Bernard – Lyon I, France

A.S. in Biology
Université de Franche-Comté, France

  • Credentials

Fellow (FACSc)
Association of Clinical Scientists 

Member (MRSB)
Royal Society of Biology

2023 –
Principal Investigator / Biology and Innovative Therapies in Ovarian Cancer
INSERM U1086 – Anticipe, France

2023 –
Assistant Research Professor / Faculty of Health Sciences, School of Pharmacy
Université de Caen – Normandie, France

2021 –
Assistant Professor / Dept. of Pharmacology and Nuclear Medicine
University of California, Los Angeles, California, USA

2019 – 2021
Faculty Lecturer / School of Pharmacy
Université de Montréal, Québec, Canada

2018 – 2021
Post-Doctoral Associate / Dept. of Pharmacology and Therapeutics
McGill University, Québec, Canada

2018 – 2018
Post-Doctoral Associate / Dept. of Pharmacology-Physiology
Université de Sherbrooke, Québec, Canada

2010 – 2017
Graduate Student / Dept. of Pharmacology-Physiology
Université de Sherbrooke, Québec, Canada

2010 – 2010
Undergraduate Research Intern / UMR 5086 – IBCP
CNRS-Université Claude-Bernard – Lyon I, France